Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2019-08-14 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
GRANT OF SHARE OPTIONS
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the grant of share options to directors, chief executive, employees, and consultants of Sinopharm Tech Holdings Limited. It details the number of options granted, exercise price, validity period, and recipients, including directors and their associates. The announcement references compliance with the GEM Listing Rules and is a formal disclosure of a share option grant event. It does not contain financial statements, audit information, or detailed financial performance data. It is not a report but a regulatory announcement about a capital-related event (share options granted). This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share option grants.
2019-08-14 English
VOLUNTARY ANNOUNCEMENT - IN RELATION TO A STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH BEIJING GUORUN JIUHE HEALTH TECHNOLOGY CO., LTD AND KENFORD MEDICAL GROUP COMPANY LIMITED
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding a strategic cooperation framework agreement with two other companies. It details the nature of the cooperation, responsibilities of the parties, background information about the companies involved, and the business rationale. There is no financial data, no regulatory filing form references, no voting results, no management or board changes, no earnings or annual report content. The document is an announcement of a business development event, specifically a strategic cooperation agreement, which fits best under general regulatory announcements. It is not a report or financial statement but an informative announcement to shareholders and investors about a new business cooperation. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length and detail confirm it is not a brief report publication announcement or a short notice but a full announcement. Confidence is high due to clear content and context.
2019-08-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2019
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/07/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. It includes confirmations related to compliance with listing rules and legal requirements. The content focuses on share capital changes and securities issuance during a specific month, which aligns with reporting on share capital changes rather than a full financial report or earnings release. The document is comprehensive and contains substantive data on share movements, not merely an announcement or certification. Therefore, it fits best under the category 'Share Issue/Capital Change' (SHA).
2019-08-06 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles, including executive, non-executive, and independent non-executive directors, as well as the composition of board committees such as Audit, Remuneration, and Nomination Committees. There is no financial data, no discussion of financial results, no voting results, no legal proceedings, no capital changes, and no mention of any report publication. The document is an announcement about the company's board structure and management roles. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, confirming this classification with high confidence.
2019-07-29 English
APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the appointment of a non-executive director, Dr. Cheng Yanjie. It details his background, qualifications, shareholding, and terms of appointment. There is no financial data, no discussion of financial results, no mention of a report or filing, and no regulatory certification. The content focuses solely on a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 6302 characters, which is sufficient for a detailed announcement but does not constitute a full report. Therefore, the appropriate classification is MANG with high confidence.
2019-07-29 English
VOLUNTARY ANNOUNCEMENT - IN RELATION TO A STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH SINOPHARM TRADITIONAL CHINESE MEDICINE CO. LTD AND ZHONG WEI HUA XIN FUND MANAGEMENT CO., LTD
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding a strategic cooperation framework agreement with other companies. It details the nature of the agreement, the parties involved, the business scope, and the potential benefits. There is no financial data, no quarterly or annual financial results, no voting results, no management changes, no legal proceedings, no merger or acquisition filings, and no regulatory certifications. The document is an announcement of a business development and cooperation plan, not a financial report or regulatory filing. It is also not a report publication announcement since it does not mention any report being published or attached. Therefore, the document fits best into the category of a general regulatory announcement about business developments, which falls under Regulatory Filings (RNS).
2019-07-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.